Repertoire Immune Medicines
Executivos
Veja o organograma con seus 13 executivos principais
Biografias mais buscadas da Repertoire Immune Medicines
Criar um alerta
para seguir os movimentos de executivos da Repertoire Immune Medicines.
Biotecnologia
Repertoire Immune Medicines possui 2.291 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Bruker has announced the acquisition of NanoString Technologies (publicado em 13 de maio de 2024).
- Aardvark Therapeutics acaba de anunciar uma arrecadação de fundos de 85 milhões de dólares. (publicado em 12 de maio de 2024).
- Bluejay Therapeutics acaba de anunciar uma arrecadação de fundos de 182 milhões de dólares. (publicado em 12 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Repertoire Immune Medicines
- Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases • Repertoire Immune Medicines
- Repertoire® Immune Medicines Presents New Data From Its DECODE™ Platform Identifying Highly Prevalent Immunotherapeutic Targets in HPV-Positive Cancers, Unlocking Pathways for Potential Therapeutics • Repertoire Immune Medicines
- Torben Straight Nissen Joins Repertoire® Immune Medicines as Chief Executive Officer • Repertoire Immune Medicines
- New Data From Repertoire® Immune Medicines Demonstrate Effectiveness of Its DECODE™ Platform to Characterize and Identify New Immunotherapeutic Targets in HPV Positive Cancer • Repertoire Immune Medicines
- Repertoire® Immune Medicines Enters New Research Collaboration to Discover The T Cell Response to Therapy in HPV-Associated Cancers • Repertoire Immune Medicines
- Repertoire® Immune Medicines Identifies Novel Immune Targets in Pathogenesis of Type 1 Diabetes • Repertoire Immune Medicines
- Preclinical Research Published in SCIENCE ADVANCES Demonstrates Repertoire Immune Medicines’ Cell-tethering Technology Delivers Potent Interleukin-12 Directly to Solid Tumors Potentially Improving Effectiveness of Cellular Immunotherapies • Repertoire Imm
- https://s3.us-east-1.amazonaws.com/repertoire-assets.investeddigital.com/downloads/Repertoire-SITC-PRESS-RELEASE_FINAL_6-Nov-2020.pdf
- https://assets.website-files.com/5ced5bd7efec584ab6889c10/5e8cdcf19cd40fc9a661a001_JDRF%20T1D%20Fund%20Repertoire%20Press%20Release_Final.pdf
- Press Releases
- View more press releases Close
Redes sociais sobre Repertoire Immune Medicines
- Repertoire Immune Medicines na Wikipedia, Google News e Yahoo Finance
- Repertoire Immune Medicines na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Susan Hockfield 
Ligue para a Repertoire Immune Medicines em +1 61...
